Community-acquired pneumonia and acid-suppressive drugs: position statement
- PMID: 16482239
- PMCID: PMC2538974
- DOI: 10.1155/2006/324976
Community-acquired pneumonia and acid-suppressive drugs: position statement
References
-
- Okie S. What ails the FDA? N Engl J Med. 2005;352:1063–6. (Erratum in 2005;352:2563) - PubMed
-
- Drazen JM. COX-2 inhibitors – a lesson in unexpected problems. N Engl J Med. 2005;352:1131–2. - PubMed
-
- Psaty BM, Furberg CD. COX-2 inhibitors – lessons in drug safety. N Engl J Med. 2005;352:1133–5. - PubMed
-
- Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292:1955–60. - PubMed
-
- Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology. 1997;112:1798–810. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical